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multiple ill-defined hypodense liver lesions (Figure 
3) consistent with hepatocellular carcinoma with 
bilateral adrenal metastases (Figure 4).
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ABSTRACT
Metastatic spread of tumors to the skull is quite unusual and often represents diagnostic and 
therapeutic issues. Skull involvement can be observed in various neoplasms of epithelial origin and 
are most often due to lung, breast, thyroid, kidney and prostate cancers. However, skull metastases 
from hepatocellular carcinoma (HCC) have been rarely reported. The prognosis for patients with 
hepatocellular carcinoma is so poor that treatment of such distant metastatic lesion cannot be 
achieved before death occurs due to the primary malignancy. Therefore, the clinical manifestations 
of cranial metastasis prior to that of primary hepatocellular carcinoma have rarely been reported. 
This case illustrates a rare case of skull metastasis as an initial manifestation of hepatocellular 
carcinoma. Although a solitary skull metastasis prior to the diagnosis of HCC demonstrates rare 
metastatic behavior for HCC, especially in Asia, skull metastases from HCC should be included in 
the differential diagnosis of skull tumors, even if the patient is asymptomatic of liver cirrhosis. 
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CASE REPORT
A 61 year-old Malay male with underlying history of 
diabetes, hypertension and Hepatitis B presented with 
painless subcutaneous swelling in the scalp of 4 months 
duration. Physical examination revealed signs of 
chronic liver disease with multiple left supraclavicular 
lymphadenopathy. No hepatosplenomegaly. A well 
defined 14.0cm x 12.0cm swelling in the right parietal 
scalp which was firm in consistency and non tender 
was present. No pus discharge was noted from the 
swelling. His serum alpha fetoprotein was high (483.9 
IU/mL). Skull radiograph followed by non contrast 
and contrasted computed tomography (CT) scan of 
the brain were done. Skull radiograph showed an 
osteolytic lesion in the right parietal bone (Figure 
1). CT brain findings revealed soft tissue mass at the 
right parietal region with adjacent bony destruction 
(Figure 2).  Subsequently, a percutaneous needle 
biopsy of the scalp lesion confirmed a metastasis from 
a multicentric hepatocellular carcinoma. A retrograde 
diagnostic work-up for detecting the primary cancer 
was then performed. An abdominal CT scan revealed 
DISCUSSION    
                                                                            
Hepatocellular carcinoma (HCC) is one of the most 
common cancers worldwide and the most common 
primary malignant tumor of the liver. The major risk 
factor for HCC is Hepatitis C, evidenced by presence 
of antibody to HCV (anti-HCV) and HCV RNA.1 Other 
risk factors include liver cirrhosis due to long standing 
chronic hepatitis B, C, or hereditary hemochromatosis 
and other metabolic disorders. Patients with 
longstanding alcoholic cirrhosis are also at risk for 
developing this tumor.1 
HCC spreads locally and metastasizes distally by 
hematogenous and lymphatic routes.1 The commonest 
site for spread of HCC is via invasion of the liver 
capsule followed by extra vascular invasion, vascular 
invasion and lastly by intrahepatic metastasis.2 It is 
been reported that extra-hepatic spreading of HCC is 
not uncommon and usually involve lymph nodes (42%), 
lungs (18%) and the adrenal gland.1,3  
This patient initially visited the hospital due to the 
incidentally discovered scalp mass. It is a similar 
presentation to the reported case by Latif A et al in 
2002. From the previous literature, metastases from 
HCC is commonly present in the skull base and less 
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is essential in order to treat the primary disease.  In 
conclusion, bone metastases from HCC are rare and it 
is even rarer to find bone metastases as the first overt 
manifestation of HCC.
frequently seen in the skull vault with a subcutaneous 
mass as the most common clinical presentation(63%). 
Other signs and symptoms are neurological deficits 
(44%), headache (11%) and seizures.1,4 Patients who 
present with neurological deficits usually manifest 
as facial palsy, deafness, visual disturbance, facial 
numbness, weakness of limbs, and other cranial 
nerve palsies, depending on the size of tumor  and its 
location.1,4 
HCC rarely metastasizes to the bones.5,6 Such osseous 
metastases are mainly of the spine or long skeletal 
bones, and only 6% to the skull bones in autopsy 
cases.7 The incidence of intracranial metastases and/
or skull metastases is extremely rare and assessed on 
the basis of postmortem studies. In all cases the plain 
skull radiograph appearance of the metastases was 
osteolytic.8 
Recently, diagnosis is reached by neurological findings 
and imaging studies, such as CT and MRI because of 
improvements in these modalities. The metastatic 
lesions appeared as expansile osteolytic masses on CT 
and as hypervascular masses on angiography. On MR 
imaging, compared with the brain parenchyma, the 
lesions were iso- or hypointense on T1-weighted and 
T2-weighted MR images. The lesions were moderately 
to markedly enhanced by intravenous gadolinium-
DTPA. The relatively hypointense tumor on T2-weighted 
MR images associated with flow void, different from 
primary skull tumors or directly invasive tumors may 
support the diagnosis of HCC metastasis.9
Hepatocellular carcinoma is an aggressive tumor 
and may be at an advanced stage when detected. 
Treatment of hepatocellular carcinoma maybe 
directed towards a cure, or focused towards palliation. 
Recently, with the advances in non-surgical treatment 
of HCC worldwide, a number of therapies that offer 
good palliation can be choosen.9 Treatment options 
are dictated by the extent and stage of the tumor 
and functional reserve of the liver. Among them are 
percutaneous ablation including percutaneous ethanol 
injection therapy (PEIT), radiofrequency ablation 
(RFA) and transcatheter embolization. All of these 
methods can prolong the survival rate of the patient 
even in advanced cases of HCC. However, they have 
their particu1ar indications, contraindications and 
complications.9   
The prognosis for patients with HCC is so poor that 
treatment of such a distant metastatic lesion cannot 
be achieved before death occurs due to the primary 
malignancy. Therefore, the clinical manifestations of 
cranial metastasis prior to that of primary HCC have 
rarely been reported.9
As illustrated by this case, the diagnosis of HCC 
should be considered in the differential diagnosis of 
patients with subcutaneous scalp mass and osteolytic 
defects on radiograph especially in the patients with 
underlying cirrhosis. An isolated skull metastasis may 
be the sole initial presentation of HCC. Early diagnosis 
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Figure 1.  Lateral skull X-ray showed an osteolytic lesion in the right posterior parietal   
     bone (arrows).
Figure 2.  Contrast enhanced CT of the brain showed a well defined enhancing soft  
     tissue mass in the right posterior parietal region with bony destruction  
     (arrows).
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Figure 3. Contrast enhanced CT of abdomen showed multiple ill-defined area of 
               heterogeneously hypodense lesion in both liver lobes with minimal    
    enhancement on arterial phase (arrows).
Figure 4. CECT showed enlarged and lobulated right and left adrenal glands with   
   minimal enhancement in keeping with adrenal metastases (arrows).
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